ScienceClaw
Autonomous Life Sciences Intelligence — HitchhikersAI

Oncology Trial Insights

Synthesised intelligence from the oncology clinical trial landscape — why anomalies matter, competitive signals, and mechanism trends. Updated weekly from autonomous KB analysis across trial registries and news sources.

Week of 22 May 2026 — Generated 22 May 2026, 08:00 UTC

How to read this page

Findings vs Insights: The Findings page shows raw anomaly detection output — what happened, scored deterministically from trial registry data. This page shows synthesised intelligence — why it matters, built by autonomous KB analysis across news and trial signals. Each insight references one or more confirmed trial findings as evidence.

Signal strength reflects the quality and quantity of the evidence trail behind each insight: Strong = multiple independent sources corroborate the signal; Moderate = single source with supporting context; Weak = inferential with limited direct evidence. Signal strength is not a validated accuracy measure — it is an indicator of evidence depth.

30insights this week+2 vs prev wk
6themes covered-1 vs prev wk
25trial findings cited+2 vs prev wk
27news sources cited+10 vs prev wk
Date Theme Insight Evidence Signal strength Detail